Abstract

BackgroundFew studies have suggested a relationship between inflammation and cerebral venous thrombosis (CVT). This retrospective study aimed to explore the changes in inflammation in different CVT stages and the correlation between inflammation and severity and outcome of CVT.MethodsIn total, 95 suitable patients with CVT and 41 controls were compared. Patients with CVT were divided into three groups. The inflammatory factors studied included hypersensitive C-reactive protein (Hs-CRP), interleukin-6 (IL-6), and neutrophil-to-lymphocyte ratio (NLR) in the peripheral blood and immunoglobulin A (IgA), immunoglobulin M (IgM), and immunoglobulin G (IgG) in the cerebrospinal fluid (CSF). The severity of CVT was evaluated with the modified Rankin Scale (mRS), the National Institutes of Health Stroke Scale (NIHSS), fundus condition, intracranial pressure (ICP), and complications on admission. The short-term outcome was evaluated with the mRS at discharge.ResultsThe following results were obtained: (1) Inflammatory factor levels in patients with CVT were higher than those in the controls. (2) Inflammatory factor levels in the acute and subacute stages were significantly higher than those in the chronic stage (all P < 0.05). (3) Serum NLR and CSF IgM levels were positively related to baseline degree of disability (odds ratio [OR], 1.279, 95% confidence interval [CI] 1.009–1.621, P = 0.042; OR 1.402, 95% CI 1.036–1.896, P = 0.028). The Hs-CRP level was positively correlated with the baseline occurrence of seizure (OR 1.040, 95% CI 1.001–1.080, P = 0.043). The baseline serum NLR (r = 0.244, P = 0.017), CSF IgA (r = 0.615, P < 0.001), CSF IgM (r = 0.752, P < 0.001), and CSF IgG (r = 0.248, P = 0.015) levels were positively associated with NIHSS. (4) The baseline NLR was significantly associated with high risk of poor outcome at discharge (OR 1.339, 95% CI 1.097–1.784, P = 0.007). Moreover, the ROC showed that NLR ≥ 4.205 could better predict the poor outcome at discharge. The data were analyzed using SPSS.ConclusionsInflammation may develop after CVT and gradually decrease during the course. Inflammation was significantly correlated with severity on admission and short-term poor outcome at discharge in CVT.

Highlights

  • Few studies have suggested a relationship between inflammation and cerebral venous thrombosis (CVT)

  • (3) Serum neutrophil-to-lymphocyte ratio (NLR) and cerebrospinal fluid (CSF) immunoglobulin M (IgM) levels were positively related to baseline degree of disability

  • The baseline serum NLR (r = 0.244, P = 0.017), CSF immunoglobulin A (IgA) (r = 0.615, P < 0.001), CSF IgM (r = 0.752, P < 0.001), and CSF immunoglobulin G (IgG) (r = 0.248, P = 0.015) levels were positively associated with National Institutes of Health Stroke Scale (NIHSS). (4) The baseline NLR was significantly associated with high risk of poor outcome at discharge

Read more

Summary

Introduction

Few studies have suggested a relationship between inflammation and cerebral venous thrombosis (CVT). This retrospective study aimed to explore the changes in inflammation in different CVT stages and the correlation between inflammation and severity and outcome of CVT. Cerebral venous thrombosis (CVT) is an uncommon type of stroke mainly developing in the young and middle-aged population, especially women [1]. Numerous studies have found that inflammation plays vital roles in many thromboembolic diseases such as acute ischemic stroke (AIS), deep venous thrombosis (DVT), and pulmonary embolism (PE) [5,6,7]. The relationship between inflammation and CVT in patients without definite inflammatory diseases remains unknown

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call